Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|
| Assets | |||||
| Cash and short-term funds | -38.09%67.83B | 15.01%106.34B | -4.47%109.55B | --92.46B | --114.68B |
| Lendings to Banks and Other Financial Institutions | ---- | 5.42%498.67M | 761.70%475.9M | --473.05M | --55.23M |
| Loans and other receivables | -99.66%51.99M | -15.52%13.6B | -11.40%15.49B | --16.1B | --17.49B |
| Financial assets at fair value | -16.06%43.71B | -14.08%45.49B | -8.93%52.07B | --52.94B | --57.18B |
| Assets to be sold | -31.92%10.53B | -36.31%12.42B | -47.45%15.46B | --19.5B | --29.43B |
| Buying back the sale of financial assets | -99.58%24.2M | -31.09%4.72B | 177.63%5.77B | --6.84B | --2.08B |
| Derivative financial assets | -76.27%973.46M | -28.40%2.59B | 44.72%4.1B | --3.62B | --2.84B |
| Investment in a joint venture | 15.01%14.39B | 12.75%14.19B | 23.02%12.51B | --12.58B | --10.17B |
| Interest in associates | 3.03%70.97B | 2.15%69.72B | -3.90%68.88B | --68.25B | --71.68B |
| Fixed assets | 4.45%56.03B | -0.37%55.02B | 11.28%53.64B | --55.23B | --48.2B |
| Investment property | 0.38%93.47B | -1.12%92.3B | -2.81%93.12B | --93.34B | --95.81B |
| Intangible Assets | 5.48%39.92B | 1.33%38.61B | 3.99%37.85B | --38.1B | --36.4B |
| Goodwill | -8.68%26.79B | -12.34%25.9B | 2.58%29.33B | --29.55B | --28.6B |
| Deferred tax assets | -14.32%8.43B | -18.39%7.97B | 16.83%9.83B | --9.77B | --8.42B |
| Special items of assets | -6.96%140.56B | -9.74%134.72B | -1.85%151.07B | --149.25B | --153.92B |
| Total assets | -10.49%735.69B | -1.47%796.53B | -1.56%821.89B | --808.39B | --834.87B |
| Liabilities | |||||
| Interbank and other financial institutions deposits (liabilities) | ---- | 105.17%2.26B | 13.88%3.8B | --1.1B | --3.34B |
| Customer deposits | -99.09%786M | 1.47%83.42B | 5.86%86.13B | --82.22B | --81.36B |
| Tax payable | -16.83%10.43B | -13.59%11.36B | 0.55%12.54B | --13.15B | --12.47B |
| Derivative financial liability | -62.75%1.75B | -17.61%3.33B | 34.54%4.69B | --4.04B | --3.49B |
| Financial assets sold for repurchase | -99.36%6.79M | 465.24%1.06B | -89.52%1.07B | --188.06M | --10.16B |
| Deferred tax liability | -5.74%20.21B | -10.91%19.55B | -6.42%21.44B | --21.94B | --22.91B |
| Special items of liabilities | 4.40%497.07B | 0.06%470.78B | -2.94%476.11B | --470.48B | --490.54B |
| Total liabilities | -12.13%538.35B | -0.14%598.99B | -2.68%612.66B | --599.81B | --629.51B |
| Total assets less total liabilities | -5.68%197.33B | -5.29%197.54B | 1.88%209.23B | --208.57B | --205.37B |
| Equity | |||||
| Share capital | 0.18%37.44B | 0.23%37.37B | 0.61%37.37B | --37.29B | --37.15B |
| Reserve | --80.88B | ---- | ---- | ---- | ---- |
| Other reserve | ---- | -7.96%80.98B | -0.63%87.73B | --87.98B | --88.29B |
| Shareholders' equity | -5.38%118.14B | -5.47%118.1B | -0.31%124.85B | --124.94B | --125.24B |
| Minority interests | -6.14%79.2B | -5.02%79.44B | 5.31%84.38B | --83.64B | --80.12B |
| Total equity | -5.68%197.33B | -5.29%197.54B | 1.88%209.23B | --208.57B | --205.37B |
| Total equity and total liabilities | -10.49%735.69B | -1.47%796.53B | -1.56%821.89B | --808.39B | --834.87B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.